Chengzhi Co Ltd Class A 000990
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 7.38
- Day Range
- CNY 7.31–7.53
- 52-Week Range
- CNY 5.96–9.14
- Bid/Ask
- CNY 7.44 / CNY 7.45
- Market Cap
- CNY 9.04 Bil
- Volume/Avg
- 11.1 Mil / 23.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 22.25
- Price/Sales
- 0.77
- Dividend Yield (Trailing)
- 0.67%
- Dividend Yield (Forward)
- 0.67%
- Total Yield
- 0.67%
Company Profile
Chengzhi Co Ltd, formerly Chengzhi Shareholding Co Ltd is a China-based company engaged in the businesses of clean energy, functional materials and medical care and health.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 4,195
- Website
- http://www.chengzhi.com.cn
Comparables
Valuation
|
Metric
|
000990
|
000403
|
300149
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.25 | 30.45 | — |
Price/Book Value | 0.51 | 2.59 | 1.38 |
Price/Sales | 0.77 | 7.77 | 1.79 |
Price/Cash Flow | 4.11 | 37.38 | 10.05 |
Price/Earnings
000990
000403
300149
Financial Strength
|
Metric
|
000990
|
000403
|
300149
|
|---|---|---|---|
Quick Ratio | 0.78 | 2.66 | 1.54 |
Current Ratio | 1.22 | 4.01 | 1.76 |
Interest Coverage | 4.64 | 88.68 | −30.81 |
Quick Ratio
000990
000403
300149
Profitability
|
Metric
|
000990
|
000403
|
300149
|
|---|---|---|---|
Return on Assets (Normalized) | 1.41% | 7.64% | −29.89% |
Return on Equity (Normalized) | 2.01% | 8.84% | −45.72% |
Return on Invested Capital (Normalized) | 1.95% | 7.59% | −33.66% |
Return on Assets
000990
000403
300149
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Ljsmlxdsv | Dgxr | $642.9 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Mypkmbqq | Qrxyf | $121.0 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Lklyktkv | Gzhryb | $115.8 Bil | |||
| Moderna Inc
MRNA
| Wzwhhkpd | Jflb | $45.5 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Kvdgpmsc | Whhvjf | $30.7 Bil | |||
| argenx SE ADR
ARGX
| Qrbrpbcv | Pytl | $26.0 Bil | |||
| BioNTech SE ADR
BNTX
| Hzkbbztk | Tsvzs | $19.4 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Cxyywmnj | Zyyydm | $15.6 Bil | |||
| United Therapeutics Corp
UTHR
| Fpcykzdq | Qwfj | $14.1 Bil | |||
| Incyte Corp
INCY
| Qqtjvjq | Qxkkwf | $11.9 Bil |